{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:47:25Z","timestamp":1793314045852,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.043","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T11:25:22Z","timestamp":1316517922000},"page":"8988-8997","source":"Crossref","is-referenced-by-count":67,"title":["Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"Iana H.","family":"Haralambieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Umlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Shane Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (47)","key":"10.1016\/j.vaccine.2011.09.043_bib0005","first-page":"1321","article-title":"Global measles mortality, 2000\u20132008","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.043_bib0010","first-page":"811","article-title":"Measles control \u2013 can measles virus inhibitors make a difference?","volume":"10","author":"Plemper","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","article-title":"Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated","volume":"125","author":"Sugerman","year":"2010","journal-title":"Pediatrics"},{"issue":"29","key":"10.1016\/j.vaccine.2011.09.043_bib0020","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1016\/j.vaccine.2010.04.084","article-title":"Measles in the United Kingdom 1990\u20132008 and the effectiveness of measles vaccines","volume":"28","author":"Jick","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.043_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/003335490812300205","article-title":"Measles outbreak associated with a church congregation: a study of immunization attitudes of congregation members","volume":"123","author":"Kennedy","year":"2008","journal-title":"Public Health Rep"},{"issue":"18","key":"10.1016\/j.vaccine.2011.09.043_bib0030","first-page":"494","article-title":"Measles \u2013 United States, January 1\u2013April 25, 2008","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2011.09.043_bib0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/522868","article-title":"Building an immunity fence against measles","volume":"196","author":"Orenstein","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.043_bib0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.043_bib0300","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/omi.2011.0032","article-title":"Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections","volume":"15","author":"Poland","year":"2011","journal-title":"Omics"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0050","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"5775","key":"10.1016\/j.vaccine.2011.09.043_bib0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2011.09.043_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.043_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2010.01.004","article-title":"2\u2032\u20135\u2032-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine","volume":"71","author":"Haralambieva","year":"2010","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.043_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/649588","article-title":"Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination","volume":"201","author":"Ovsyannikova","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00439-009-0763-1","article-title":"Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes","volume":"127","author":"Ovsyannikova","year":"2010","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.043_bib0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000025035","article-title":"Identification of a single nucleotide polymorphism in the M\u00d7A gene promoter (G\/T at nt -88) correlated with the response of hepatitis C patients to interferon","volume":"43","author":"Hijikata","year":"2000","journal-title":"Intervirology"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2893.2004.00509.x","article-title":"Single nucleotide polymorphism of the M\u00d7A gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection","volume":"11","author":"Suzuki","year":"2004","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/01.WNL.0000106940.95749.8E","article-title":"Functional M\u00d7A promoter polymorphism associated with subacute sclerosing panencephalitis","volume":"62","author":"Torisu","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.043_bib0100","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/jhep.2002.37198","article-title":"Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: a pilot study","volume":"36","author":"King","year":"2002","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.vaccine.2011.09.043_bib0105","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/497340","article-title":"Single nucleotide polymorphisms in genes for 2\u2032\u20135\u2032-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection","volume":"192","author":"Yakub","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.043_bib0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.gene.6363984","article-title":"Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of M\u00d7A, OAS-1 and PKR","volume":"4","author":"Knapp","year":"2003","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0115","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbrc.2005.02.101","article-title":"Polymorphisms of interferon-inducible genes OAS-1 and M\u00d7A associated with SARS in the Vietnamese population","volume":"329","author":"Hamano","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2334-6-106","article-title":"Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and M\u00d7A genes: a case\u2013control study","volume":"6","author":"He","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2011.09.043_bib0125","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0130","doi-asserted-by":"crossref","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011;(Mar), in press, doi:10.1007\/s00439-011-0977-x.","DOI":"10.1007\/s00439-011-0977-x"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.043_bib0135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/CVI.00008-08","article-title":"Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles immunity","volume":"15","author":"Haralambieva","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.043_bib0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/00365510500348252","article-title":"Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma secreting T cells","volume":"65","author":"Ryan","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virol.2007.02.028","article-title":"HLA homozygosity does not adversely effect measles vaccine-induced cytokine responses","volume":"364","author":"Ovsyannikova","year":"2007","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.09.043_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2008.11.001","article-title":"Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination","volume":"341","author":"Ryan","year":"2009","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","article-title":"Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium","volume":"74","author":"Carlson","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004390100505","article-title":"Nomenclature for the description of human sequence variations","volume":"109","author":"den Dunnen","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0165","series-title":"Genetic data Analysis II: methods for discrete population genetic data","author":"Weir","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.043_bib0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J R Statist Soc B"},{"issue":"16","key":"10.1016\/j.vaccine.2011.09.043_bib0185","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-010-0423-6","article-title":"SNP\/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine","volume":"62","author":"Dhiman","year":"2010","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.043_bib0195","doi-asserted-by":"crossref","first-page":"e1000321","DOI":"10.1371\/journal.ppat.1000321","article-title":"Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man","volume":"5","author":"Lim","year":"2009","journal-title":"PLoS Pathogens"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0200","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"33","key":"10.1016\/j.vaccine.2011.09.043_bib0205","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.vaccine.2011.05.068","article-title":"SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine","volume":"29","author":"Clifford","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0210","doi-asserted-by":"crossref","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, O\u2019Byrne MM, Jacobson RM, Poland GA. The association of CD46, SLAM, and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses \u2013 a replication study and examination of novel polymorphisms. Hum Hered 2011; (Aug), in press.","DOI":"10.1159\/000331585"},{"issue":"14","key":"10.1016\/j.vaccine.2011.09.043_bib0215","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/510596","article-title":"Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes","volume":"195","author":"Dhiman","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0225","doi-asserted-by":"crossref","unstructured":"Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine, 2011;(Aug), in press, doi:10.1016\/j.vaccine.2011.08.083.","DOI":"10.1016\/j.vaccine.2011.08.083"},{"issue":"50","key":"10.1016\/j.vaccine.2011.09.043_bib0230","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/j.vaccine.2009.09.076","article-title":"Influence of cytokine gene variations on immunization to childhood vaccines","volume":"27","author":"Yucesoy","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/infdis\/jir268","article-title":"Common SNPs\/Haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in caucasians and African-Americans","volume":"204","author":"Haralambieva","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0039.2008.01097.x","article-title":"Associations between cytokine\/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population","volume":"72","author":"Dhiman","year":"2008","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.043_bib0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.immuni.2008.05.005","article-title":"Regulation of mitochondrial antiviral signaling pathways","volume":"28","author":"Moore","year":"2008","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.vaccine.2011.09.043_bib0250","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1074\/jbc.R700007200","article-title":"Function of RIG-I-like receptors in antiviral innate immunity","volume":"282","author":"Yoneyama","year":"2007","journal-title":"J Biol Chem"},{"issue":"9071","key":"10.1016\/j.vaccine.2011.09.043_bib0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(96)12019-5","article-title":"Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa","volume":"350","author":"Benn","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.043_bib0260","doi-asserted-by":"crossref","first-page":"e22323","DOI":"10.1371\/journal.pone.0022323","article-title":"RIG-I is required for the inhibition of measles virus by retinoids","volume":"6","author":"Soye","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/JVI.01690-09","article-title":"Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha\/beta interferon in measles virus-infected human cells","volume":"84","author":"Ikegame","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.043_bib0270","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.0903291","article-title":"A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells","volume":"185","author":"Hu","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0275","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/429391","article-title":"Variation in antiviral 2\u2032,5\u2032-oligoadenylate synthetase (2\u20325\u2032AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene","volume":"76","author":"Bonnevie-Nielsen","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"46","key":"10.1016\/j.vaccine.2011.09.043_bib0280","doi-asserted-by":"crossref","first-page":"45833","DOI":"10.1074\/jbc.M308612200","article-title":"Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2011.09.043_bib0285","doi-asserted-by":"crossref","unstructured":"Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, et al. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol 2011;24(5), in press, doi:10.1089\/vim.2011.0029.","DOI":"10.1089\/vim.2011.0029"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.043_bib0290","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.immuni.2007.08.012","article-title":"Innate recognition of viruses","volume":"27","author":"Pichlmair","year":"2007","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.043_bib0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000073201","article-title":"Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes","volume":"55","author":"Martin","year":"2003","journal-title":"Hum Hered"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T01:50:25Z","timestamp":1560649825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":59,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11014496"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}